About this Journal Submit a Manuscript Table of Contents
Anesthesiology Research and Practice
Volume 2012 (2012), Article ID 356982, 16 pages
http://dx.doi.org/10.1155/2012/356982
Review Article

Perioperative Anesthesiological Management of Patients with Pulmonary Hypertension

1Klinikum St. Georg gGmbH, Klinik für Anästhesiologie, Intensiv und Schmerztherapie, Delitzscher Straße 141, 04129 Leipzig, Germany
2Medical Clinic and Polyclinic I, Department of Pneumology, Universitätsklinikum Leipzig AöR, 04103 Leipzig, Germany
3Clinic for Anesthesiology and Critical Care Medicine, Martin Luther University of Halle-Wittenberg, 06120 Halle, Germany

Received 3 May 2012; Revised 2 August 2012; Accepted 16 August 2012

Academic Editor: Ronald G. Pearl

Copyright © 2012 Jochen Gille et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Ramakrishna, J. Sprung, B. S. Ravi, K. Chandrasekaran, and M. D. McGoon, “Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality,” Journal of the American College of Cardiology, vol. 45, no. 10, pp. 1691–1699, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. R. M. Rodriguez and R. G. Pearl, “Pulmonary hypertension and major surgery,” Anesthesia and Analgesia, vol. 87, no. 4, pp. 812–815, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. N. V. Roberts and P. J. Keast, “Pulmonary hypertension and pregnancy—a lethal combination,” Anaesthesia and Intensive Care, vol. 18, no. 3, pp. 366–374, 1990. View at Scopus
  4. D. L. Reich, C. A. Bodian, M. Krol, M. Kuroda, T. Osinski, and D. M. Thys, “Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery,” Anesthesia and Analgesia, vol. 89, no. 4, pp. 814–822, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Shimizu, H. Takahashi, N. Matsumiya, M. Miyabe, and M. Tanaka, “Unsuccessful anesthetic management for cesarean section in a patient with primary pulmonary hypertension,” Japanese Journal of Anesthesiology, vol. 56, no. 8, pp. 949–952, 2007. View at Scopus
  6. R. Kaw, V. Pasupuleti, A. Deshpande, T. Hamieh, E. Walker, and O. A. Minai, “Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery,” Respiratory Medicine, vol. 105, no. 4, pp. 619–624, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Simonneau, I. M. Robbins, M. Beghetti et al., “Updated clinical classification of pulmonary hypertension,” Journal of the American College of Cardiology, vol. 54, no. 1, supplement, pp. S43–S54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Galiè, M.M. Hoeper, M. Humbert, et al., “Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS), endorsed by the international society of heart and lung transplantation (ISHLT),” European Heart Journal, vol. 30, no. 20, pp. 2493–2537, 2009.
  9. G. Kovacs, R. Maier, E. Aberer et al., “Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 9, pp. 881–886, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Kovacs, A. Berghold, S. Scheidl, and H. Olschewski, “Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review,” European Respiratory Journal, vol. 34, no. 4, pp. 888–894, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. N. W. Morrell, S. Adnot, S. L. Archer et al., “Cellular and molecular basis of pulmonary arterial hypertension,” Journal of the American College of Cardiology, vol. 54, no. 1, supplement, pp. S20–S31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Humbert, O. Sitbon, A. Chaouat et al., “Pulmonary arterial hypertension in France: results from a national registry,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 9, pp. 1023–1030, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Pengo, A. W. A. Lensing, M. H. Prins et al., “Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism,” The New England Journal of Medicine, vol. 350, no. 22, pp. 2257–2364, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Thabut, G. Dauriat, J. B. Stern et al., “Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation,” Chest, vol. 127, no. 5, pp. 1531–1536, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. Hoeper Mm, S. Andreas, A. Bastian, et al., “Pulmonale Hypertonie bei chronischen Lungenerkrankungen. Empfehlungen der Kölner Konsensus-Konferenz 2010,” Deutsche Medizinische Wochenschrift, vol. 135, pp. 115–124, 2010.
  16. C. M. Westby, B. R. Weil, J. J. Greiner, B. L. Stauffer, and C. A. DeSouza, “Endothelin-1 vasoconstriction and the age-related decline in endothelium-dependent vasodilatation in men,” Clinical Science, vol. 120, no. 11, pp. 485–491, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. L. J. Rubin, D. B. Badesch, R. J. Barst et al., “Bosentan therapy for pulmonary arterial hypertension,” The New England Journal of Medicine, vol. 346, no. 12, pp. 896–903, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Humbert, E. S. Segal, D. G. Kiely, J. Carlsen, B. Schwierin, and M. M. Hoeper, “Results of European post-marketing surveillance of bosentan in pulmonary hypertension,” European Respiratory Journal, vol. 30, no. 2, pp. 338–344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Galiè, H. Olschewski, R. J. Oudiz et al., “Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-Blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2,” Circulation, vol. 117, no. 23, pp. 3010–3019, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. L. J. Rubin, D. B. Badesch, T. R. Fleming, et al., “Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: SUPER-2,” Chest, vol. 140, no. 5, pp. 1274–1283, 2011.
  21. N. Galiè, B. H. Brundage, H. A. Ghofrani et al., “Tadalafil therapy for pulmonary arterial hypertension,” Circulation, vol. 119, no. 22, pp. 2894–2903, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Olschewski, G. Simonneau, N. Galie, et al., “Inhaled iloprost for severe pulmonary hypertension,” The New England Journal of Medicine, vol. 347, no. 5, pp. 322–329, 2002. View at Publisher · View at Google Scholar
  23. M. Gomberg-Maitland and H. Olschewski, “Prostacyclin therapies for the treatment of pulmonary arterial hypertension,” European Respiratory Journal, vol. 31, no. 4, pp. 891–901, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Jaïs, A. M. D'Armini, P. Jansa et al., “Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension. BENEFiT (bosentan effects in inoperable forms of chronic thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial,” Journal of the American College of Cardiology, vol. 52, no. 25, pp. 2127–2134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. H. J. Seyfarth, M. Halank, H. Wilkens et al., “Standard PAH therapy improves long term survival in CTEPH patients,” Clinical Research in Cardiology, vol. 99, no. 9, pp. 553–556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Subramaniam and J. P. Yared, “Management of pulmonary hypertension in the operating room,” Seminars in Cardiothoracic and Vascular Anesthesia, vol. 11, no. 2, pp. 119–136, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Preckel, S. Eberl, J. Fraessdorf, et al., “Management of patients with pulmonary hypertension,” Anaesthesist, vol. 61, no. 7, pp. 574–587, 2012. View at Publisher · View at Google Scholar
  28. V. V. McLaughlin, S. L. Archer, D. B. Badesch et al., “ACCF/AHA 2009 expert consensus document on pulmonary hypertension. A report of the American college of cardiology foundation task force on expert consensus documents and the American heart association developed in collaboration with the American college of chest physicians; American thoracic society, Inc.; and the pulmonary hypertension association,” Journal of the American College of Cardiology, vol. 53, no. 17, pp. 1573–1619, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Gruenig, A. Barner, M. Bell, et al., “Nichtinvasive Diagnostik der pulmonalen Hypertonie. ESC/ERS-Leitlinien mit Kommentierung der Kölner Konsenus-Konferenz 2010,” Deutsche Medizinische Wochenschrift, vol. 135, pp. 67–77, 2010.
  30. L. G. Fischer, H. van Aken, and H. Bürkle, “Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists,” Anesthesia and Analgesia, vol. 96, no. 6, pp. 1603–1616, 2003. View at Scopus
  31. C. Fox, P. L. Kalarickal, M. J. Yarborough, and J. Y. Jin, “Perioperative management including new pharmacological vistas for patients with pulmonary hypertension for noncardiac surgery,” Current Opinion in Anaesthesiology, vol. 21, no. 4, pp. 467–472, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. C. K. Hofer, A. Senn, L. Weibel, et al., “Assessment of stroke volume variation for prediction of fluid responsiveness using the modified FloTrac and PiCCOplus system,” Critical Care, vol. 12, article R82, 2008. View at Publisher · View at Google Scholar
  33. Schulmeyer Mcc, E. Santelices, R. Vega, et al., “Impact of intraoperative transesophageal echocardiography during noncardiac surgery,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 20, no. 6, pp. 768–771, 2006. View at Publisher · View at Google Scholar
  34. N. Kolev, R. Brase, J. Swanevelder et al., “The influence of transoesophageal echocardiography on intra-operative decision making. A European multicentre study,” Anaesthesia, vol. 53, no. 8, pp. 767–773, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. C. K. Hofer, A. Zollinger, M. Rak et al., “Therapeutic impact of intra-operative transoesophageal echocardiography during noncardiac surgery,” Anaesthesia, vol. 59, no. 1, pp. 3–9, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. J. I. Poelaert, J. Trouerbach, M. de Buyzere, J. Everaert, and F. A. Colardyn, “Evaluation of transesophageal echocardiography as a diagnostic and therapeutic aid in a critical care setting,” Chest, vol. 107, no. 3, pp. 774–779, 1995. View at Scopus
  37. T. Rinne and B. Zwissler, “Intraoperative anesthetic management in patients with pulmonary hypertension,” Intensiv-und Notfallbehandlung, vol. 29, no. 1, pp. 4–13, 2004. View at Scopus
  38. S. Krug, A. Sablotzki, S. Hammerschmidt, H. Wirtz, and H. J. Seyfarth, “Inhaled iloprost for the control of pulmonary hypertension,” Vascular Health and Risk Management, vol. 5, pp. 465–474, 2009. View at Scopus
  39. R. Crowley, E. Sanchez, J. K. Ho, et al., “Prolonged central venous desaturation measured by continuous oximetry is associated with adverse outcomes in pediatric cardiac surgery,” Anesthesiology, vol. 115, no. 5, pp. 1033–1043, 2011. View at Publisher · View at Google Scholar
  40. S. Nebout and R. Pirrachio, “Should we monitor ScVO2 in critically ill patients ?” Cardiology Research and Practice, vol. 2012, Article ID 370697, 7 pages, 2012. View at Publisher · View at Google Scholar
  41. C. D. Pritts and R. G. Pearl, “Anesthesia for patients with pulmonary hypertension,” Current Opinion in Anaesthesiology, vol. 23, no. 3, pp. 411–416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Jenkins, A. Lynn, J. Edmonds, and G. Barker, “Effects of mechanical ventilation on cardiopulmonary function in children after open-heart surgery,” Critical Care Medicine, vol. 13, no. 2, pp. 77–80, 1985. View at Scopus
  43. V. Von Dossow, M. Welte, U. Zaune et al., “Thoracic epidural anesthesia combined with general anesthesia: the preferred anesthetic technique for thoracic surgery,” Anesthesia and Analgesia, vol. 92, no. 4, pp. 848–854, 2001. View at Scopus
  44. B. T. Veering and M. J. Cousins, “Cardiovascular and pulmonary effects of epidural anaesthesia,” Anaesthesia and Intensive Care, vol. 28, no. 6, pp. 620–635, 2000. View at Scopus
  45. J. B. Pollard, “Common mechanisms and strategies for prevention and treatment of cardiac arrest during epidural anesthesia,” Journal of Clinical Anesthesia, vol. 14, no. 1, pp. 52–56, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Bonnin, F. J. Mercier, O. Sitbon et al., “Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases,” Anesthesiology, vol. 102, no. 6, pp. 1133–1137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. D. G. Kiely, R. Condliffe, V. Webster et al., “Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach,” BJOG: An International Journal of Obstetrics and Gynaecology, vol. 117, no. 5, pp. 565–574, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. W. Gogarten, E. Vandermeulen, H. van Aken, S. Kozek, J. V. Llau, and C. M. Samama, “Regional anaesthesia and antithrombotic agents: recommendations of the European society of anaesthesiology,” European Journal of Anaesthesiology, vol. 27, no. 12, pp. 999–1015, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. T. T. Horlocker, D. J. Wedel, J. C. Rowlingson et al., “Regional Anesthesia in the patient receiving antithrombotic or thrombolytic therapy; American society of regional anesthesia and pain medicine evidence-based guidelines (third edition),” Regional Anesthesia and Pain Medicine, vol. 35, no. 1, pp. 64–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Blaise, D. Langleben, and B. Hubert, “Pulmonary arterial hypertension: pathophysiology and anesthetic approach,” Anesthesiology, vol. 99, no. 6, pp. 1415–1432, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Mertens, V. Saldien, H. Coppejans, K. Bettens, and M. Vercauteren, “Target controlled infusion of remifentanil and propofol for cesarean section in a patient with multivalvular disease and severe pulmonary hypertension,” Acta Anaesthesiologica Belgica, vol. 52, no. 2, pp. 207–209, 2001. View at Scopus
  52. G. F. Rich, C. M. Roos, S. M. Anderson, M. O. Daugherty, and D. R. Uncles, “Direct effects of intravenous anesthetics on pulmonary vascular resistance in the isolated rat lung,” Anesthesia and Analgesia, vol. 78, no. 5, pp. 961–966, 1994. View at Scopus
  53. L. M. Gambone, P. A. Murray, and N. A. Flavahan, “Isoflurane anesthesia attenuates endotheliumdependent pulmonary vasorelaxation by inhibiting the synergistic interaction between nitric oxide and prostacyclin,” Anesthesiology, vol. 86, no. 4, pp. 936–944, 1997. View at Scopus
  54. M. Nakayama, U. Kondo, and P. A. Murray, “Pulmonary vasodilator response to adenosine triphosphate—sensitive potassium channel activation is attenuated during desflurane but preserved during sevoflurane anesthesia compared with the conscious state,” Anesthesiology, vol. 88, no. 4, pp. 1023–1035, 1998. View at Publisher · View at Google Scholar · View at Scopus
  55. P. R. Hickey, D. D. Hansen, G. M. Cramolini, R. N. Vincent, and P. Lang, “Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance,” Anesthesiology, vol. 62, no. 3, pp. 287–293, 1985. View at Scopus
  56. K. Wiedemann and C. Diestelhorst, “The effect of sedation on pulmonary function,” Anaesthesist, vol. 44, supplement 3, pp. S588–S593, 1995. View at Scopus
  57. D. Tempe, J. C. Mohan, A. Cooper, et al., “Myocardial depressant effect of nitrous oxide after valve surgery,” European Journal of Anaesthesiology, vol. 11, no. 353, p. 358, 1994.
  58. G. D. Williams, H. Maan, C. Ramamoorthy et al., “Perioperative complications in children with pulmonary hypertension undergoing general anesthesia with ketamine,” Paediatric Anaesthesia, vol. 20, no. 1, pp. 28–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. L. C. Price, S. J. Wort, S. J. Finney, P. S. Marino, and S. J. Brett, “Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review,” Critical Care, vol. 14, no. 5, article 169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. B. Stobierska-Dzierzek, H. Awad, and R. E. Michler, “The evolving management of acute right-sided heart failure in cardiac transplant recipients,” Journal of the American College of Cardiology, vol. 38, no. 4, pp. 923–931, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Carl, A. Alms, J. Braun, et al., “S3 guidelines for intensive care in cardiac surgery patients: hemodynamic monitoring and cardiocirculatory system,” German Medical Science, vol. 8, Article ID Doc12, 2010. View at Publisher · View at Google Scholar
  62. Y. W. Teo and D. L. Greenhalgh, “Update on anaesthetic approach to pulmonary hypertension,” European Journal of Anaesthesiology, vol. 27, no. 4, pp. 317–323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. E. Czeslick, T. Hentschel, I. Friedrich, et al., “Inhalierbare Vasodilatatoren in der kardiochirurgischen Intensivmedizin,” Zeitschrift für Herz-,Thorax-und Gefäßchirurgie, vol. 19, pp. 132–145, 2005.
  64. P. Forrest, “Anaesthesia and right ventricular failure,” Anaesthesia and Intensive Care, vol. 37, no. 3, pp. 370–385, 2009. View at Scopus
  65. E. P. Chen, H. B. Bittner, R. D. Davis, and P. van Trigt, “Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension,” Annals of Thoracic Surgery, vol. 63, no. 3, pp. 814–821, 1997. View at Publisher · View at Google Scholar · View at Scopus
  66. C. D. Vizza, G. D. Rocca, D. A. Roma et al., “Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension,” Critical Care, vol. 5, no. 6, pp. 355–361, 2001. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Walmrath, R. Schermuly, J. Pilch, F. Grimminger, and W. Seeger, “Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension,” European Respiratory Journal, vol. 10, no. 5, pp. 1084–1092, 1997. View at Scopus
  68. J. Pepke-Zaba, T. W. Higenbottam, A. T. Dinh-Xuan, D. Stone, and J. Wallwork, “Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension,” The Lancet, vol. 338, no. 8776, pp. 1173–1174, 1991. View at Publisher · View at Google Scholar · View at Scopus
  69. W. Steudel, W. E. Hurford, and W. M. Zapol, “Inhaled nitric oxide: basic biology and clinical applications,” Anesthesiology, vol. 91, no. 4, pp. 1090–1121, 1999. View at Publisher · View at Google Scholar · View at Scopus
  70. W. E. Hurford and L. M. Bigatello, “NO-body's perfect,” Anesthesiology, vol. 96, no. 6, pp. 1285–1287, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. I. Ibrahim, J. R. Ninnis, A. O. Hopper, et al., “Inhaled nitric oxide therapy increases blood nitrite, nitrate, and s-nitrosohemoglobin concentrations in infants with pulmonary hypertension,” Journal of Pediatrics, vol. 160, no. 2, pp. 245–251, 2012. View at Publisher · View at Google Scholar
  72. D. Walmrath, T. Schneider, R. Schermuly, H. Olschewski, F. Grimminger, and W. Seeger, “Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 3, pp. 991–996, 1996. View at Scopus
  73. R. A. Schroeder, G. L. Wood, J. S. Plotkin, and P. C. Kuo, “Intraoperative use of inhaled PGI2 for acute pulmonary hypertension and right ventricular failure,” Anesthesia and Analgesia, vol. 91, no. 2, pp. 291–295, 2000. View at Scopus
  74. M. Haché, A. Y. Denault, S. Bélisle et al., “Inhaled prostacyclin (PGI2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit,” Canadian Journal of Anesthesia, vol. 48, no. 9, pp. 924–929, 2001. View at Scopus
  75. M. Winterhalter, T. Antoniou, and T. Loukanov, “Management of adult patients with perioperative pulmonary hypertension: technical aspects and therapeutic options,” Cardiology, vol. 116, no. 1, pp. 3–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Rex, T. Busch, M. Vettelschoss, L. de Rossi, R. Rossaint, and W. Buhre, “Intraoperative management of severe pulmonary hypertension during cardiac surgery with inhaled iloprost,” Anesthesiology, vol. 99, no. 3, pp. 745–747, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. T. Kramm, B. Eberle, S. Guth, and E. Mayer, “Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy,” European Journal of Cardio-Thoracic Surgery, vol. 28, no. 6, pp. 882–888, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Gessler, T. Schmehl, M. M. Hoeper et al., “Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension,” European Respiratory Journal, vol. 17, no. 1, pp. 14–19, 2001. View at Publisher · View at Google Scholar · View at Scopus
  79. T. Loukanov, D. Bucsenez, W. Springer et al., “Comparison of inhaled nitric oxide with aerosolized iloprost for treatment of pulmonary hypertension in children after cardiopulmonary bypass surgery,” Clinical Research in Cardiology, vol. 100, no. 7, pp. 595–602, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. S. Krug, S. Hammerschmidt, H. Pankau, H. Wirtz, and H. J. Seyfarth, “Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension,” Respiration, vol. 76, no. 2, pp. 154–159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. N. Yurtseven, P. Karaca, G. Uysal et al., “A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery,” Annals of Thoracic and Cardiovascular Surgery, vol. 12, no. 5, pp. 319–323, 2006. View at Scopus
  82. C. A. Elliot, P. Stewart, V. J. Webster et al., “The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension,” European Respiratory Journal, vol. 26, no. 1, pp. 168–173, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Haraldsson, N. Kieler-Jensen, and S. E. Ricksten, “The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension,” Anesthesia and Analgesia, vol. 93, no. 6, pp. 1439–1445, 2001. View at Scopus
  84. Y. Lamarche, L. P. Perrault, S. Maltais, K. Tétreault, J. Lambert, and A. Y. Denault, “Preliminary experience with inhaled milrinone in cardiac surgery,” European Journal of Cardio-thoracic Surgery, vol. 31, no. 6, pp. 1081–1087, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Sablotzki, W. Startzmann, R. Scheubel, S. Grond, and E. G. Czeslick, “Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates,” Canadian Journal of Anesthesia, vol. 52, no. 10, pp. 1076–1082, 2005. View at Scopus
  86. H. A. Ghofrani, F. Rose, R. T. Schermuly et al., “Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertension,” Critical Care Medicine, vol. 30, no. 11, pp. 2489–2492, 2002. View at Scopus
  87. H. Wang, M. Gong, B. Zhou, and A. Dai, “Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery,” Advances in Therapy, vol. 26, no. 4, pp. 462–468, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Huang, M. J. Bouvette, and J. Zhou, “Simultaneous delivery of inhaled prostacyclin and milrinone through a double nebulizer system,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 25, no. 3, pp. 590–591, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. G. Simonneau, R. J. Barst, N. Galie et al., “Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 6, pp. 800–804, 2002. View at Scopus
  90. B. L. Levarge and R. N. Channick, “Inhaled treprostinil for the treatment of pulmonary arterial hypertension,” Expert Review of Respiratory Medicine, vol. 6, no. 3, pp. 255–265, 2012. View at Publisher · View at Google Scholar
  91. R. N. Channick, R. Voswinckel, and L. J. Rubin, “Inhaled treprostinil: a therapeutic review,” Drug Design, Development and Therapy, vol. 6, pp. 19–28, 2012.
  92. R. Voswinckel, B. Enke, F. Reichenberger et al., “Favorable effects of inhaled treprostinil in severe pulmonary hypertension. Results from randomized controlled pilot studies,” Journal of the American College of Cardiology, vol. 48, no. 8, pp. 1672–1681, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. E. Loh, J. S. Stamler, J. M. Hare, J. Loscalzo, and W. S. Colucci, “Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction,” Circulation, vol. 90, no. 6, pp. 2780–2785, 1994. View at Scopus
  94. M. J. Semigran, B. A. Cockrill, R. Kacmarek et al., “Hemodynamic effects of inhaled nitric oxide in heart failure,” Journal of the American College of Cardiology, vol. 24, no. 4, pp. 982–988, 1994. View at Scopus